Prognosis of Chronic Kidney Disease and Metabolic Syndrome in Adults With Congenital Heart Disease.
Adults
Chronic Kidney Disease
Congenital Heart Defect
Metabolic Syndrome
Journal
Journal of Korean medical science
ISSN: 1598-6357
Titre abrégé: J Korean Med Sci
Pays: Korea (South)
ID NLM: 8703518
Informations de publication
Date de publication:
20 Nov 2023
20 Nov 2023
Historique:
received:
16
04
2023
accepted:
22
08
2023
medline:
22
11
2023
pubmed:
21
11
2023
entrez:
21
11
2023
Statut:
epublish
Résumé
Few studies have examined the incidence of chronic kidney disease (CKD) and metabolic syndrome (MS) and their combined prognostic effects in adult congenital heart disease (ACHD). Our aims were to identify the incidence and prognostic implications of CKD and MS in ACHD. This is retrospective cohort study. We included 2,462 ACHD ≥ 20 years of age who were treated at a tertiary hospital in Korea from 2006 to 2018. CKD was defined as an estimated glomerular filtration rate < 60 mL/min/1.73m². MS was diagnosed based on the presence of abnormal metabolic parameters: blood sugar level, obesity, dyslipidemia, and hypertension. The primary outcome was all-cause mortality from 2006 through 2019 using data from the Ministry of the Interior and Safety in Korea. The incidence of CKD and MS in ACHD was 7.6% and 35.9%, respectively. The coexistence rate of CKD and MS was 4.6%. Although MS was not independently associated with mortality in the multiple analysis (adjusted hazard ratio [aHR], 1.07; 95% confidence interval [CI], 0.79-1.46), it was closely related to the presence of CKD (adjusted odds ratio, 2.62; 95% CI, 1.89-3.63). ACHD patients with CKD had a significantly increased risk of mortality compared with those without CKD (aHR, 2.84; 95% CI, 2.00-4.04). In patients with ACHD, the distribution of MS is higher, and both MS and its components were associated with CKD. Given the CKD was independently associated with mortality, close monitoring and management of renal dysfunction and metabolic parameters in ACHD patients is needed.
Sections du résumé
BACKGROUND
BACKGROUND
Few studies have examined the incidence of chronic kidney disease (CKD) and metabolic syndrome (MS) and their combined prognostic effects in adult congenital heart disease (ACHD). Our aims were to identify the incidence and prognostic implications of CKD and MS in ACHD.
METHODS
METHODS
This is retrospective cohort study. We included 2,462 ACHD ≥ 20 years of age who were treated at a tertiary hospital in Korea from 2006 to 2018. CKD was defined as an estimated glomerular filtration rate < 60 mL/min/1.73m². MS was diagnosed based on the presence of abnormal metabolic parameters: blood sugar level, obesity, dyslipidemia, and hypertension. The primary outcome was all-cause mortality from 2006 through 2019 using data from the Ministry of the Interior and Safety in Korea.
RESULTS
RESULTS
The incidence of CKD and MS in ACHD was 7.6% and 35.9%, respectively. The coexistence rate of CKD and MS was 4.6%. Although MS was not independently associated with mortality in the multiple analysis (adjusted hazard ratio [aHR], 1.07; 95% confidence interval [CI], 0.79-1.46), it was closely related to the presence of CKD (adjusted odds ratio, 2.62; 95% CI, 1.89-3.63). ACHD patients with CKD had a significantly increased risk of mortality compared with those without CKD (aHR, 2.84; 95% CI, 2.00-4.04).
CONCLUSIONS
CONCLUSIONS
In patients with ACHD, the distribution of MS is higher, and both MS and its components were associated with CKD. Given the CKD was independently associated with mortality, close monitoring and management of renal dysfunction and metabolic parameters in ACHD patients is needed.
Identifiants
pubmed: 37987105
pii: 38.e375
doi: 10.3346/jkms.2023.38.e375
pmc: PMC10659921
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e375Informations de copyright
© 2023 The Korean Academy of Medical Sciences.
Déclaration de conflit d'intérêts
The authors have no potential conflicts of interest to disclose.
Références
Int J Cardiol. 2017 Dec 1;248:143-148
pubmed: 28705603
Heart. 2008 Sep;94(9):1194-9
pubmed: 17646191
Am J Cardiol. 2017 Dec 15;120(12):2272-2277
pubmed: 29111211
Can J Kidney Health Dis. 2015 Aug 11;2:27
pubmed: 26266042
PLoS One. 2015 Feb 23;10(2):e0116844
pubmed: 25706872
Eur Heart J. 2010 May;31(10):1220-9
pubmed: 20207625
Cardiol Young. 2014 Feb;24(1):40-6
pubmed: 23328503
PLoS One. 2018 Mar 22;13(3):e0194490
pubmed: 29566051
Prog Cardiovasc Dis. 2018 Jul - Aug;61(2):142-150
pubmed: 29981771
Prev Chronic Dis. 2017 Mar 16;14:E24
pubmed: 28301314
Metab Syndr Relat Disord. 2019 Feb;17(1):46-52
pubmed: 30484738
Vasc Health Risk Manag. 2019 May 01;15:89-100
pubmed: 31118651
Cardiooncology. 2022 Nov 23;8(1):20
pubmed: 36419184
Int J Artif Organs. 2001 Oct;24(10):695-725
pubmed: 11817319
Yonsei Med J. 2022 Dec;63(12):1069-1077
pubmed: 36444542
Nephron. 2018;139(4):313-318
pubmed: 29791905
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Transl Res. 2017 May;183:57-70
pubmed: 28130064
J Am Coll Cardiol. 2011 Sep 27;58(14):1509-15
pubmed: 21939837
J Am Heart Assoc. 2016 Feb 23;5(2):
pubmed: 26908411
PLoS One. 2016 Jul 06;11(7):e0158765
pubmed: 27383068
J Am Heart Assoc. 2016 Feb 12;5(2):
pubmed: 26873680
Heart. 2017 Aug;103(16):1250-1257
pubmed: 28237971
Circulation. 2021 Mar 16;143(11):1157-1172
pubmed: 33720773
J Am Coll Cardiol. 2001 Apr;37(5):1170-5
pubmed: 11300418
JAMA. 1999 May 12;281(18):1714-7
pubmed: 10328071
Medicine (Baltimore). 2018 Jul;97(27):e11348
pubmed: 29979412
J Korean Med Sci. 2022 Sep 05;37(18):e149
pubmed: 35535376
Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):612-6
pubmed: 16874153
JAMA Netw Open. 2019 Jul 3;2(7):e196762
pubmed: 31276179
J Public Health (Oxf). 2010 Dec;32(4):538-46
pubmed: 20061374
J Am Coll Cardiol. 2008 Dec 2;52(23):e143-e263
pubmed: 19038677
Circulation. 2008 May 6;117(18):2320-8
pubmed: 18443238
Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):537-47
pubmed: 26826295
Eur Heart J. 2021 Jul 8;42(26):2577-2586
pubmed: 33219678
Korean Circ J. 2019 Aug;49(8):691-708
pubmed: 31347322
Atherosclerosis. 2018 Oct;277:47-52
pubmed: 30172084
Korean Circ J. 2015 Sep;45(5):416-23
pubmed: 26413110